Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies

TOP News

Vialek Book Banner

Study Shows Prescription of Unnecessarily Long Antibiotics Courses

People are being prescribed unnecessarily long courses of antibiotics which may increase their risk of developing antibiotic resistant infections, a study has suggested. A recent study looked at 93...

NICE Review on its Drug Development Guidances

Following approval at its recent Board meeting NICE has confirmed the details of its review of the methods it uses to develop guidance on drugs, medical devices and diagnostics. The purpose of the ...

Sysmex Opened New Production Facility in Moscow Region

Japanese Sysmex, the world leader in comprehensive solutions for in vitro diagnostics, particularly in hematology, flow cytometry and urinalysis, opened new production facility in Bogorodsky Industria...

Expanded Roche’s Global Access Program Now Includes MTB, HPV, Hepatitis B and C

Roche announced the Global Access Program is expanding beyond HIV, to include Mycobacterium tuberculosis (MTB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV) for low and middle incom...

Preparation for New Track & Trace Regulation in Russia

Company to install new inspection cameras with higher resolution to ensure readability of more complex codes demanded by the Russian mandated crypto coding. Legacy Pharmaceuticals, a global contract ...

Gilead Sciences Licensed Three Preclinical Antiviral Programs from Novartis

gilead
Gilead Sciences, Inc. announced that it has licensed three preclinical antiviral programs from Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and he...

Takeda Announced Results of the VISIBLE 2 Clinical Trials Evaluating Vedolizumab

takeda hq tokyo
Takeda Pharmaceutical Company Limited announced top-line results from the VISIBLE 2 clinical trial evaluating the efficacy and safety of an investigational subcutaneous (SC) formulation of the gut-sel...

Subscribe to GMP news Newsletter!

Interview

SID&GP about MoU and Relatioship with UK

On January 29, the UK and Russia have signed a memorandum of understanding enhancing cooperation in the field of regulation of medicines. Radio Sputnik discussed the development with Nikolay Tsatsy...

InterPharm Technology Group®. Exceeding the expectations over 20 years

For 20 years, InterPharmTechnology Group® holds a prominent position in the market of pharmaceutical technological equipment in Russia and other EAEU member states.

Dara Pharma: Modern Pharmaceutical Equipment from Spain

David Rarl
One of the key factors that ensure that the manufacturers of drugs comply with GMP standards, is the implementation of modern technological equipment in their production plants which will be subsequen...

Counterfeit products will even not get into the licensed pharmacy chains

murashko
Russian State Duma adopted a bill on labeling of medicinal products with Data Matrix labels. This procedure will become mandatory from January 1, 2020

Subscribe to GMP news Newsletter!

Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies